Gene · 259307
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage-mediated activation of the IL4I1/AhR axis is a key player in allergic rhinitis. | Int Immunopharmacol | 2025 | 40080924 | PubTator, text mining | PubMed |
| Tryptophan Metabolic Enzyme IL4I1 Inhibits Ferroptosis by Decreasing Ubiquitination of Nrf2 via I3P in Glioblastoma. | Cell Prolif | 2025 | 40071723 | PubTator, text mining | PubMed |
| Regulating macrophage phenotypes with IL4I1-mimetic nanoparticles in IDD treatment. | J Nanobiotechnology | 2025 | 40050923 | PubTator, text mining | PubMed |
| STANCE: a unified statistical model to detect cell-type-specific spatially variable genes in spatial transcriptomics. | Nat Commun | 2025 | 39979358 | PubTator, text mining | PubMed |
| Dual role of mucosal-associated invariant T cells (MAIT) in asthma. | J Asthma | 2025 | 39969254 | PubTator, text mining | PubMed |
| Designing the Aplysia punctata Arginine-Depleting Enzyme for Tumor Targeting. | Mol Pharm | 2025 | 39950605 | PubTator, text mining | PubMed |
| Energetic and Electronic Properties of AcX and LaX (X = O and F). | J Phys Chem A | 2025 | 39874522 | PubTator, text mining | PubMed |
| Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy. | Pharmaceuticals (Basel) | 2025 | 39861117 | PubTator, text mining | PubMed |
| Electrochemical Biosensors 3D Printed by Fused Deposition Modeling: Actualities, Trends, and Challenges. | Biosensors (Basel) | 2025 | 39852108 | PubTator, text mining | PubMed |
| Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma. | J Transl Med | 2025 | 39844281 | PubTator, text mining | PubMed |
| Amitriptyline revitalizes ICB response via dually inhibiting Kyn/Indole and 5-HT pathways of tryptophan metabolism in ovarian cancer. | iScience | 2024 | 39759009 | PubTator, text mining | PubMed |
| The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies. | Toxins (Basel) | 2024 | 39728777 | PubTator, text mining | PubMed |
| Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrent tumor lesions. | Commun Biol | 2024 | 39702554 | PubTator, text mining | PubMed |
| Proteomic Profiling of Venoms from Bungarus suzhenae and B. bungaroides: Enzymatic Activities and Toxicity Assessment. | Toxins (Basel) | 2024 | 39591249 | PubTator, text mining | PubMed |
| Immune Microenvironment Alterations and Identification of Key Diagnostic Biomarkers in Chronic Kidney Disease Using Integrated Bioinformatics and Machine Learning. | Pharmgenomics Pers Med | 2024 | 39588536 | PubTator, text mining | PubMed |
| Novel Prognostic Markers for Skin Cutaneous Melanoma. | Clin Cosmet Investig Dermatol | 2024 | 39588228 | PubTator, text mining | PubMed |
| Renal remodeling by CXCL10-CXCR3 axis-recruited mesenchymal stem cells and subsequent IL4I1 secretion in lupus nephritis. | Signal Transduct Target Ther | 2024 | 39557841 | PubTator, text mining | PubMed |
| Interplay of human macrophage response and natural resistance of L. ( V .) panamensis to pentavalent antimony. | bioRxiv | 2024 | 39553936 | PubTator, text mining | PubMed |
| Analysis of Naja kaouthia snake venom composition and in-vitro enzymatic activities of 29 specimens in captivity: Highlighting the importance of individual variation in venom pool production. | Toxicon | 2024 | 39542145 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259307/papers?page=6